(2S,3S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLPENTANOATE
Compound with spectra: 1 NMR
![(2S,3S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLPENTANOATE](/api/compound/LJkKhVYfgEG.png?ph=true&h=300&w=458 "(2S,3S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLPENTANOATE")
| SpectraBase Compound ID | LJkKhVYfgEG |
|---|---|
| InChI | InChI=1S/C13H18FN3O5/c1-4-7(2)10(12(20)22-3)15-9(18)6-17-5-8(14)11(19)16-13(17)21/h5,7,10H,4,6H2,1-3H3,(H,15,18)(H,16,19,21)/t7-,10-/m0/s1 |
| InChIKey | XSRWQIBNXBQKDK-XVKPBYJWSA-N |
| Mol Weight | 315.3 g/mol |
| Molecular Formula | C13H18FN3O5 |
| Exact Mass | 315.123049 g/mol |
| Enantiomer InChIKey | XSRWQIBNXBQKDK-GMSGAONNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(S)-DIMETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-PENTANEDIOATE
(S)-DIMETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-SUCCINATE
N-{[5-Methyl-4-(methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-valine Methyl Ester
N-{[6-Methyl-4-(methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-valine Methyl Ester
1 -(3 -(4 -Acetylaminobenzenesulfonamido) -3 -oxopropyl) -5 -fluoropyrimidine-2,4 -dione
N-{[6-Methyl-4-(methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-leucine Methyl Ester
(+-)-[(1SR,3RS)-2,2-difluoro-3-hydroxymethylcyclopropylmethyl]-5-fluoro1,2,3,4-tetrahydro-2,4-pyrimidindione
N-{[4-(Methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-phenylglycine Methyl Ester
N-[(2,4-dioxo-5-fluoro-1,2,3,4-tetrahydro-1-pyrimidinyl)carbonyl]methionine, ethyl ester
(+/-)-5-fluoro-1-(1,4-oxathiin-2-yl)uracil
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antitumor Activity of Amino Acid Ester Derivatives Containing 5-Fluorouracil | Molecules | 2009 |